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model;	 and	 (c)	 clinical	 knowledge	 versus	 scope	of	 care	 by	 the	 anticoagulation	 staff.	
These	themes	linked	to	three	key	areas	of	variation,	including:	(a)	the	size	and	hospital	
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farin.1	 Expert	 nurses	 and	pharmacists	within	 these	 clinics	 provide	
high-	level	 care	 leading	 to	 improved	 patient	 satisfaction	 and	 high-	
quality	warfarin	management.	In	recent	years,	the	use	of	direct	oral	
anticoagulants	 (DOACs)	 for	 patients	who	 traditionally	would	 have	
received	warfarin	therapy	has	grown	rapidly.2	While	these	DOAC-	
treated	 patients	 face	 many	 of	 the	 same	 challenges	 as	 warfarin-	












2.1 | Study design and subject recruitment
Our	mixed-	methods	study	involved	two	methods	of	data	collection.	
The	 quantitative	 data	 was	 collected	 via	 an	 online	 survey	 of	 anti-
coagulation	 clinic	 providers	 (Online	 Appendix).	 Details	 have	 been	
published	previously.4	Briefly,	we	invited	all	active	members	of	the	
Anticoagulation	 Forum	 (a	 large	 peer	 organization	 of	 anticoagula-
tion	service	providers	in	North	America)	to	participate	in	an	online	
survey.	We	excluded	responses	from	anticoagulation	clinics	located	
outside	 the	United	States,	 clinics	who	serviced	only	 inpatients,	or	
duplicate	responses.
The	 qualitative	 data	 was	 collected	 through	 semi-	structured	
interviews	 with	 anticoagulation	 clinic	 leaders	 (Online	 Appendix).	
During	the	survey,	 if	participants	responded	affirmatively	to	a	sur-









assistants,	 one	 nurse	 practitioner,	 and	 one	 physician	 from	 the	 re-
search	team.	Interviews	were	conducted	in	person	with	anticoagula-
tion	clinic	leaders	at	the	Anticoagulation	Forum	Meeting.	Interviews	
lasted	 an	 average	 of	 35	minutes.	We	 developed	 a	 semi-	structured	









together	 and	 came	 to	 a	 consensus	 on	 coding	 as	well	 as	what	major	
themes	could	be	pulled	from	the	transcripts.	The	research	assistants	
and	 a	 research	 coordinator	 came	 together	 to	 develop	 a	 codebook	
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2.4 | Quantitative analytic approach
Survey	respondents	were	limited	to	those	residing	and	working	within	
the	 United	 States.	 Duplicate	 responses	 were	 eliminated	 to	 ensure	







Statistical	 analysis	 was	 performed	 using	 Stata	 version	 14.2	
(StataCorp,	College	Station,	 TX).	 Summary	 statistics	 (mean	±	stan-
dard	deviation	[SD]	or	median	and	interquartile	range	[IQR])	are	pre-
sented	for	all	analyses.
2.5 | Regulatory oversight and project sponsorship
This	project	was	reviewed	and	deemed	exempt	from	regulation	by	the	
University	 of	 Michigan	 institutional	 review	 board	 (HUM00126169).	





Three	primary	 themes	emerged	 from	 the	qualitative	 interviews	as	
key	 barriers	 to	 incorporating	 DOAC	 patients	 into	 anticoagulation	























based	model,	 and	75	of	158	 (47.5%)	use	a	 combination	of	 these	ap-


















































































































































justment	 for	 renal	 function),	 they	frequently	saw	that	physicians	and	






















“Each	 new	 provider	 that	 comes	 into	 the	 facility	 is	
trained	 on	 how	 to	 refer	 and	 they	 are	 required	 in	
their	 training	 process	 to	 do	 a	 training	 session	 on	
anticoagulation.”




reports	 that	 will	 let	 us	 know	 the	 patients	 that	 are	
scheduled	 for	 procedures,	 uh,	 as	 well	 as	 the	 major	



















versus	 their	 scope	of	 care.	 These	barriers	were	 largely	 influenced	
by	the	size	and	type	of	anticoagulation	clinic,	the	method	by	which	
patients	 interacted	with	the	clinic	and	had	 INR	 labs	collected,	and	





ratory	monitoring	 for	DOAC	patients,	 there	has	not	been	as	 ro-
bust	a	consideration	for	the	other	services	anticoagulation	clinics	
provide	patients	and	how	DOAC-	treated	patients	might	benefit.	
Our	 study	 highlights	 that	 most	 anticoagulation	 clinic	 providers	
and	 leaders	 recognize	 an	 important	 role	 in	 helping	 to	 care	 for	
these	 patients;	 however,	 they	 experience	 important	 barriers	 to	
implementing	protocols	and	clinical	pathways	for	DOAC	care.	We	
have	 previously	 highlighted	 the	 role	 that	 anticoagulation	 clinics	
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should	have	in	assisting	with	DOAC	management.	These	include	
providing	assistance	with	drug	and	dose	 selection,	ongoing	 lab-
oratory	monitoring	 (especially	of	 renal	 function),	 and	assistance	
with	peri-	procedural	management.	Each	of	these	is	a	key	patient	





other	 determinants	 of	 successful	 program	 implementation	 are	 also	







































structure	and	 function.	While	 some	clinics	have	developed	 innovative	
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